CLINICAL_TRIALS
trial_result
· 2018-12-14
Clinical Trial Update: A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Summary
Phase 2 trial evaluating PRM-151 in idiopathic pulmonary fibrosis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-14